Brigatinib Clinical Trials
4 recruitingDrug
Phase 22Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 2
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Neurofibromatosis type 2MeningiomaEpendymoma+2 more
Scott R. Plotkin, MD, PhD109 enrolled6 locationsNCT04374305
Recruiting
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer (NSCLC)
Takeda500 enrolled1 locationNCT05100069
Recruiting
Phase 1Phase 2
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Anaplastic Large Cell Lymphoma, ALK-PositiveInflammatory Myofibroblastic TumorOther Solid Tumor
Princess Maxima Center for Pediatric Oncology65 enrolled2 locationsNCT04925609
Recruiting
ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
NSCLC Stage IVSex DisorderHypogonadism, Male+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS80 enrolled1 locationNCT06532149